In VHL-deficient renal cell carcinoma (RCC), HIF-2α has been demonstrated to be the key oncogenic driver, while HIF-1α also contributes by supporting tumor metabolism [35,36,37]. This evidence concerns the gene EPAS1 and renal cell carcinoma.